DAWN
Price
$9.60
Change
-$0.03 (-0.31%)
Updated
Dec 24 closing price
Capitalization
985.68M
73 days until earnings call
Intraday BUY SELL Signals
MNKD
Price
$5.93
Change
-$0.00 (-0.00%)
Updated
Dec 24 closing price
Capitalization
1.82B
67 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DAWN vs MNKD

Header iconDAWN vs MNKD Comparison
Open Charts DAWN vs MNKDBanner chart's image
Day One Biopharmaceuticals
Price$9.60
Change-$0.03 (-0.31%)
Volume$931.08K
Capitalization985.68M
MannKind
Price$5.93
Change-$0.00 (-0.00%)
Volume$907.37K
Capitalization1.82B
DAWN vs MNKD Comparison Chart in %
DAWN
Daily Signal:
Gain/Loss:
MNKD
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
DAWN vs. MNKD commentary
Dec 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DAWN is a Hold and MNKD is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 26, 2025
Stock price -- (DAWN: $9.60 vs. MNKD: $5.93)
Brand notoriety: DAWN and MNKD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DAWN: 33% vs. MNKD: 25%
Market capitalization -- DAWN: $985.68M vs. MNKD: $1.82B
DAWN [@Biotechnology] is valued at $985.68M. MNKD’s [@Biotechnology] market capitalization is $1.82B. The market cap for tickers in the [@Biotechnology] industry ranges from $117.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DAWN’s FA Score shows that 0 FA rating(s) are green whileMNKD’s FA Score has 0 green FA rating(s).

  • DAWN’s FA Score: 0 green, 5 red.
  • MNKD’s FA Score: 0 green, 5 red.
According to our system of comparison, DAWN is a better buy in the long-term than MNKD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DAWN’s TA Score shows that 5 TA indicator(s) are bullish while MNKD’s TA Score has 6 bullish TA indicator(s).

  • DAWN’s TA Score: 5 bullish, 5 bearish.
  • MNKD’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, MNKD is a better buy in the short-term than DAWN.

Price Growth

DAWN (@Biotechnology) experienced а +9.59% price change this week, while MNKD (@Biotechnology) price change was -0.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.88%. For the same industry, the average monthly price growth was +4.46%, and the average quarterly price growth was +55.39%.

Reported Earning Dates

DAWN is expected to report earnings on Mar 09, 2026.

MNKD is expected to report earnings on Mar 03, 2026.

Industries' Descriptions

@Biotechnology (+2.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MNKD($1.82B) has a higher market cap than DAWN($986M). MNKD YTD gains are higher at: -7.776 vs. DAWN (-24.230). MNKD has higher annual earnings (EBITDA): 73.2M vs. DAWN (-162.07M). DAWN has more cash in the bank: 452M vs. MNKD (260M). DAWN has less debt than MNKD: DAWN (2.89M) vs MNKD (120M). MNKD has higher revenues than DAWN: MNKD (314M) vs DAWN (134M).
DAWNMNKDDAWN / MNKD
Capitalization986M1.82B54%
EBITDA-162.07M73.2M-221%
Gain YTD-24.230-7.776312%
P/E RatioN/A59.30-
Revenue134M314M43%
Total Cash452M260M174%
Total Debt2.89M120M2%
FUNDAMENTALS RATINGS
MNKD: Fundamental Ratings
MNKD
OUTLOOK RATING
1..100
18
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
PROFIT vs RISK RATING
1..100
56
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
84
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DAWNMNKD
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
71%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 16 days ago
80%
Declines
ODDS (%)
Bearish Trend 11 days ago
80%
Bearish Trend 18 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
72%
View a ticker or compare two or three
Interact to see
Advertisement
DAWN
Daily Signal:
Gain/Loss:
MNKD
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYLDX203.942.28
+1.13%
Rydex Dow 2x Strategy A
TOTTX10.100.05
+0.50%
Transamerica Mid Cap Value Opps I3
ACEIX11.070.04
+0.36%
Invesco Equity and Income A
VAAGX26.750.04
+0.15%
Virtus NFJ Large-Cap Value R6
BRXVX17.36N/A
N/A
MFS Blended Research Intl Eq R6

DAWN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DAWN has been loosely correlated with VCYT. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if DAWN jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DAWN
1D Price
Change %
DAWN100%
-0.31%
VCYT - DAWN
43%
Loosely correlated
-0.35%
XNCR - DAWN
42%
Loosely correlated
-0.13%
RVMD - DAWN
42%
Loosely correlated
+1.15%
DNLI - DAWN
42%
Loosely correlated
+1.07%
REPL - DAWN
42%
Loosely correlated
+3.81%
More

MNKD and

Correlation & Price change

A.I.dvisor indicates that over the last year, MNKD has been loosely correlated with IONS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if MNKD jumps, then IONS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MNKD
1D Price
Change %
MNKD100%
N/A
IONS - MNKD
48%
Loosely correlated
+0.40%
VCYT - MNKD
44%
Loosely correlated
-0.35%
INSM - MNKD
40%
Loosely correlated
+0.37%
DAWN - MNKD
37%
Loosely correlated
-0.31%
UTHR - MNKD
37%
Loosely correlated
+0.82%
More